Cite
HARVARD Citation
Ikenaga, H. et al. (2022). Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment. Journal of viral hepatitis. 29 (1), pp. 52-59. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ikenaga, H. et al. (2022). Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment. Journal of viral hepatitis. 29 (1), pp. 52-59. [Online].